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Abstract
The precise mechanism by which the binding of a class I cytokine to the extracellular domain of its corresponding receptor
transmits a signal through the cell membrane remains unclear. Receptor activation involves a cytokine-receptor complex
with a 1:2 stoichiometry. Previously we used our transient-complex theory to calculate the rate constant of the initial
cytokine-receptor binding to form a 1:1 complex. Here we computed the binding pathway leading to the 1:2 activation
complex. Three cytokine systems (growth hormone, erythropoietin, and prolactin) were studied, and the focus was on the
binding of the extracellular domain of the second receptor molecule after forming the 1:1 complex. According to the
transient-complex theory, translational and rotation diffusion of the binding entities bring them together to form a transient
complex, which has near-native relative separation and orientation but not the short-range specific native interactions.
Subsequently conformational rearrangement leads to the formation of the native complex. We found that the changes in
relative orientations between the two receptor molecules from the transient complex to the 1:2 native complex are similar
for the three cytokine-receptor systems. We thus propose a common model for receptor activation by class I cytokines,
involving combined scissor-like rotation and self-rotation of the two receptor molecules. Both types of rotations seem
essential: the scissor-like rotation separates the intracellular domains of the two receptor molecules to make room for the
associated Janus kinase molecules, while the self-rotation allows them to orient properly for transphosphorylation. This
activation model explains a host of experimental observations. The transient-complex based approach presented here may
provide a strategy for designing antagonists and prove useful for elucidating activation mechanisms of other receptors.
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Introduction
Cytokines are a large family of small proteins that bind to
specific cell surface receptors to initiate signals critical for cell
proliferation, differentiation, and apoptosis. Among the best
characterized cytokines are class I helical cytokines, including
growth hormone (GH), erythropoietin (EPO), and prolactin (PRL).
Each of these cytokines has two receptor binding sites, referred to
as site 1 and site 2, with high and low affinities, respectively. Each
cytokine receptor consists of an extracellular domain (ECD) and
an intracellular domain (ICD), connected by a single transmem-
brane helix (TMH). The ECD in turn is composed of two b-
sandwich subdomains linked by a short hinge [1]. It is well known
that the binding of two receptor molecules, to site 1 and site 2 on
the cytokine, results in receptor activation, leading to transphos-
phorylation of two Janus kinase 2 (JAK2) molecules, each
associated with a receptor ICD at a proline-rich region (box 1).
Once phosphorylated, the JAK2 molecules initiate downstream
signaling [2–5].
The structures of the 1:2 complexes of GH, EPO, and PRL with
the ECDs of the corresponding receptors have been determined
[1,6,7] (Figure 1). The structures are overall similar, but differ in
many details. Each cytokine contacts both ECD subdomains of
each receptor molecule around the hinge. The two C-terminal
subdomains are nearly parallel to each other (and presumably to
the normal of the cell membrane), while the two N-terminal
domains lie on a plane parallel to the membrane, at 130u–160u
angles. These structures have been very valuable, but they do not
reveal the rearrangement of the two ECDs induced by the
cytokine binding. Since the structures lack the TMHs and the
ICDs, there is also no information on the ICDs’ rearrangement,
which initiates downstream signaling. The aim of the present study
is to compute the cytokine-induced rearrangement of the ECDs
and develop a detailed model for receptor activation.
In the early model proposed by Fuh et al. [8] for GH receptor
activation, GH first binds to one receptor molecule via site 1, and
then recruits the second receptor molecules via site 2. This
sequential receptor-dimerization model was based on three
important observations. First, site 1 has much higher affinity than
site 2. Second, a G120R mutation disrupting site 2 did not affect
receptor binding to site 1 but abolished GH-induced cell
proliferation. Third, the dose response curve of cell proliferation
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molecule by a separate GH molecule (via site 1) interferes with
receptor dimerization and signaling.
It is now clear that receptors likely exist as preformed dimers in
the absence of the cytokines [9–11]. For both GH receptor (GHR)
and EPO receptor (EPOR), the TMHs are implicated in dimer
formation [10,12,13]. However, dimerization alone is insufficient
for activation. For example, two EPO mimetic peptides (EMP1
and EMP33) bind to EPOR to form 1:2 complexes, but in each of
these complexes the ECDs (and their subdomains) have an
orientational arrangement that is different from that in the
EPO:(EPOR)2 complex [6,14,15]. (EMP1 and EMP33 each are
present as dimers in the complexes with two EPORs. We treat
these dimers as a single ligand and refer to the stoichiometry of the
complexes as 1:2.) In signaling EMP1 acted as a partial agonist but
EMP33 as an antagonist. Seubert et al. [16] engineered EPOR
dimers by replacing the ECDs with a dimeric coiled coil. Through
deletions of up to 6 residues, they explored the full range of relative
orientation of the two TMHs in the EPOR dimers, and found one
of them to be constitutively active in cell proliferation.
For GHR, Rowlinson et al. [17] found monoclonal antibodies
that competed against GH for GHR binding but failed to act as
agonists, again indicating that dimerization is insufficient for
activation. Brown et al. [10] demonstrated constitutive dimer
formation of GHR by FRET experiments, and after inserting
alanine residues in the TMH or in the sequence immediately
before box 1, observed constitutive activity. Interestingly, consti-
tutive activity required different numbers of inserted alanine
residues in the TMH and before box 1.
The deletion and insertion results of Seubert et al. [16] and
Brown et al. [10] suggest that rotation of the TMH is involved in
receptor activation. However, the orientational rearrangement of
the ECDs that is induced by cytokine binding and triggers the
TMH rotation remains unclear.
Even in binding to a preformed dimer, it is still believed that
engagement of site 1 precedes engagement of site 2 [5,10,18]. The
initial step, i.e., the binding of a cytokine to the first receptor
molecule (R1) via site 1, leads to a 1:1 complex. The 1:1 complex is
very likely an on-pathway intermediate since the structures of the
1:1 complexes formed by GH and GHR ECD [19,20] and by
PRL and PRL receptor (PRLR) ECD [21] are very similar to
those in the corresponding 1:2 complexes [1,7,22]. The 1:1
complexes were obtained by introducing the site-2 disrupting
mutation G120R to GH and a corresponding mutation, G129R,
to PRL.
Recently we calculated the rate constants for forming the 1:1
complexes of PRL, GH, and EPO [23], using our transient-
complex theory [24]. These rate constants differ by 5000-fold,
mostly arising from differing levels of charge complementarity
across the site-1 interface. Moreover, the rate constants of the
initial binding apparently anti-correlate with the circulation
concentrations of the cytokines, such that the pseudo-first order
receptor binding rate constants are close to the limits set by the
half-lives of the receptors, ensuring their participation in cytokine
binding before internalization and degradation.
The transient complex in a binding process refers to an
intermediate that has near-native relative separation and orienta-
tion but not the short-range specific interactions of the native
complex, and is formed by translational and rotational diffusion of
the subunits. The transient complex is located at the rim of the
energy well of the native complex, and is therefore a late on-
pathway intermediate. Structural differences between the transient
complex and the native complex reveal the orientational
rearrangement of the subunits at the late stage of the binding
process. This stage starts after some of the native contacts are
already in proximity, but before the precise fit of all the native
contacts. As such it is at a critical juncture of the binding process.
Yet its characterization enjoys certain technical advantages. First,
because we focus on the late stage, we completely avoid any issues
Figure 1. Structures of the 1:2 complexes. (A) GH:(GHR)2. (B) EPO:(EPOR)2. (C) PRL:(PRLR)2. The cytokine (GH, EPO, or PRL) is in the middle in
green; receptor 2 (R2) is on the left and receptor 1 (R1) is on the right. Each receptor ECD is composed of an N-terminal subdomain (N1 in purple and
N2 in blue) and a C-terminal subdomain (C1 in orange and C2 in red).
doi:10.1371/journal.pcbi.1002427.g001
Author Summary
Class I cytokines activate their receptors via a 1:2 complex,
but the conformational rearrangements leading to recep-
tor activation remain unclear. To elucidate the activation
mechanism, here we calculated the transient complex, an
on-pathway intermediate close to the 1:2 complex. Similar
rotational motions were found for three cytokine (growth
hormone, erythropoietin, and prolactin) receptors on
going from the transient complex to the 1:2 complex.
They involve both scissor-like rotation between the
extracellular domains of two receptor molecules and self-
rotation of the molecules. Based on these results, we
propose a common model for receptor activation by class I
cytokines. The model explains a number of experimental
observations, including differences in receptor orientations
between erythropoietin and its antagonistic and partially
agonistic mimetics. Transient complexes present a novel
type of targets for designing antagonists. The detailed
activation model developed here and our transient-
complex based approach will be useful for studying the
activation mechanisms of other receptors.
Activation Mechanism of Cytokine Receptors
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2-dimensional diffusion of the membrane-bound receptors.
Second, because the transient complex is formed before the for-
mation of the stereospecific native contacts, we also avoid the
necessity of accurately treating the native contacts. Instead, the
transient-complex ensemble is largely dictated by the shape of
the binding interface.
Here we applied the transient-complex theory to study the
binding of a second receptor molecule (R2) to a 1:1 complex, to
form the 1:2 activation complex. By calculating the transient
complex for this step, we identified the orientational rearrange-
ment between the ECDs of R1 and R2 leading to receptor
activation. Similar rotational motions were found for three
cytokine-receptor systems (GH, EPO, and PRL with their
receptors). At the start of the late-stage orientational rearrange-
ment, R2 is loosely bound to the 1:1 complex around site 2 of the
cytokine, with the C-terminal subdomains of R1 and R2 far apart.
R1 and R2 then rotate like a scissor, around an axis along the N-
terminal subdomain of R2, to close up the membrane-proximal
ends of the two C-terminal subdomains. In addition, R1 and R2
both self-rotate but to different extents, such that the angle
between the two N-terminal subdomains is reduced. We propose
that the scissor-like rotation separates the intracellular domains of
the two receptor molecules to make room for the associated Janus
kinase molecules, while the self-rotation allows them to orient
properly for transphosphorylation. This common model for
receptor activation explains a host of experimental observations
on the three cytokine-receptor systems.
Results/Discussion
The focus of the present study is the late-stage orientational
rearrangement between the two receptor molecules in forming the
1:2 complex. The start of the late stage is the transient complex, in
which R2 is loosely bound to the 1:1 complex around site 2 of the
cytokine. The transient complex is identified by mapping the
energy landscape over the native-complex energy well and the
surrounding region, using the structure of the native complex as
input [24,25]. Within the native-complex well, the rotational
freedom of the subunits is severely restricted. As the two subunits
separate, there is a sudden increase in the rotational freedom. The
transient complex is identified with the midpoint of this transition,
which is largely dictated by the shape of the binding interface.
Receptor activation occurs at cell membranes, where receptors
likely exist as preformed dimers. However, the rate constants for
binding to the 1:1 complex by R2 ECD coming from the bulk
solution, rather than from a preformed receptor dimer, have been
measured for the GH-GHR and PRL-PRLR systems [22,26]. Our
transient-complex theory can make accurate predictions for the
rate constants of protein association in bulk solution, as
demonstrated by results spanning five orders of magnitude for
49 protein complexes [25]. We carried out rate constant
calculations for the 1:2 complexes of the three cytokines with the
corresponding receptor ECDs. The results were within the range,
10
4 to 10
6 M
21 s
21, of the in vitro measurements (see Supporting
Text S1 for details and implication for R2 binding to the 1:1
complex in the cellular environments).
Transient complexes of three cytokine-receptor systems
Each transient complex was an ensemble of configurations
located at the rim of the native-complex energy well. It was
generated from the structure of the 1:2 complex and would be a
late on-pathway intermediate, even if R2 came from a preformed
receptor dimer.
As noted above, the transient complex was identified by
mapping the energy landscape over the native-complex energy
well and the surrounding region. The internal conformations of
R2 and the 1:1 complex (referred to as two subunits) were fixed at
those in the 1:2 native complex. This is justified since the available
structures of the isolated 1:1 complexes of the GH and PRL
systems [19–21] are very similar to those in the corresponding 1:2
complexes [1,7,22] (with Ca RMSDs of ,1.2 A ˚); similarly the
structures of apo GHR [10] and of apo EPOR [9] as well as
EPORs in EMP1:(EPOR)2 and EMP33:(EPOR)2 [14,15] are
similar to the R2 structures in the respective 1:2 complexes for GH
and EPO (with Ca RMSDs of ,1.3 A ˚). In particular, there is no
evidence for significant change in the relative orientation between
the N-terminal and C-terminal subdomains of either ECD upon
forming any 1:2 complex. (Calculations using some of these
alternative structures as well as those taken from molecular
dynamics simulations of the 1:2 complexes produced similar
results.) There were then only six remaining degrees of freedom in
mapping the inter-subunit energy landscape: three for relative
separation and three for relative rotation.
To facilitate describing the orientational rearrangement on
going from the transient complex to the native complex, we refer
to the N-terminal and C-terminal subdomains of the R1 ECD as
N1 and C1, and analogously N2 and C2 for the subdomains of
R2. We present orientational changes as rotations of R2 relative to
R1. To that end, we define a coordinate system in which the z axis
is the long axis of C1 (directed upward), the y axis is perpendicular
to the long axes of C1 and N2, and consequently the x axis is in the
plane defined by the two long axes and roughly parallel to the N2
long axis (Figure 2A). We refer to the view into the z axis as top
view, and the view into the x axis as side view. Figure 2B–D
presents the configurations of the receptor molecules in the 1:2
native complexes of the three systems in these two viewing
directions.
In Figure 3 we display 5 representative transient-complex
configurations each for the GH-GHR, EPO-EPOR, and PRL-
PRLR systems. The top view shows that, for each of the three
systems, R2 undergoes clockwise rotation around the z axis on
going from the transient complex to the 1:2 native complex. This
‘‘self-rotation’’ is most prominent for N2 and less so for C2, since
the latter is roughly parallel to the rotation axis (i.e., z axis).
Meanwhile the side view shows that, again for each of the three
systems, R2 undergoes counterclockwise rotation around the x axis
on going from the transient complex to the 1:2 native complex.
This ‘‘scissor-like rotation’’ brings together the membrane-
proximal ends of C1 and C2.
To quantitatively characterize the orientational rearrangement,
we define two angles: c for the angle between the projections of the
N1 and N2 long axes on the x-y plane; and Q for the angle between
the projections of the C1 and C2 long axes on the y-z plane. The
values of these angles in the native complexes of are: c=163u and
Q=27u in GH:(GHR)2; c=132u and Q=0u in EPO:(EPOR)2;
and c=157u and Q=20u in PRL:(PRLR)2 (Figure 2B–D). From
the transient complex to the native complex, clockwise self-
rotation can be recognized as a decrease in c, and scissor-like
rotation can be recognized as a decrease in Q. The distributions of
c and Q in the transient complexes of the three systems are shown
in Figures S1, S2, and S3. The distributions are asymmetric with
respect to the c and Q values in the native complexes, with higher
values more favored in the transient complexes, supporting the
self-rotation and scissor-like rotation illustrated in Figure 3 on
going from the transient complex to the native complex.
Mark and co-workers [27,28] carried out molecular dynamics
simulations of (GHR)2 after removing GH from its 2:1 complex
Activation Mechanism of Cytokine Receptors
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former simulations they found prominent self-rotation correspond-
ing to that depicted in the top view of Figure 3A. In the latter
simulations they found prominent scissor-like rotation correspond-
ing to that depicted in the side view of Figure 3C. The simulation
results thus accord well with our transient-complex calculations.
Examination of the structures of the three 1:2 native complexes
revealed that the asymmetry in Q can be attributed to the
Figure 2. Top and side views of the relative orientations between R1 and R2 in the 1:2 complexes. Cytokines are removed for clarity. (A)
A coordinate system for defining the top and side views. The long axis of the C1 subdomain, identified with the principal axis corresponding to the
largest moment of inertia, was chosen as the z axis (pointing upward). The x axis was chosen to be in the plane defined by the long axes of the C1
and N2 subdomains. This coordinate system is illustrated by the (GHR)2 complex, viewing into the y axis. Top (left) and side (right) views of (GHR)2,
(EPOR)2, and (PRLR)2 are displayed in (B)–(D), with the cytokine names listed in the middle. In (B) and (D) side views, N2 is not displayed. In (C), C1 and
C2 are not displayed in the top view, and N1 and N2 are not displayed in the side view. The coloring scheme in (A), (B), and (D) is the same as in
Figure 1. In (C) the two EPORs in EMP1:(EPOR)2 and EMP3:(EPOR)2 are also displayed; receptors in complex with EPO, EMP1, and EMP33 are displayed
in cyan, pink, and lime green, respectively (except that C1 in the side view is in orange). The values of c and Q angles are also shown.
doi:10.1371/journal.pcbi.1002427.g002
Activation Mechanism of Cytokine Receptors
PLoS Computational Biology | www.ploscompbiol.org 4 March 2012 | Volume 8 | Issue 3 | e1002427Activation Mechanism of Cytokine Receptors
PLoS Computational Biology | www.ploscompbiol.org 5 March 2012 | Volume 8 | Issue 3 | e1002427wrapping of a C1 loop (between strands A and B) around C2
(Figure S4). A C2 configuration with Q lower than the native value
tends to encounter steric clash with the C1 loop. In contrast, C1
presents a relatively flat surface on the side of the native C2 where
Q is higher than the native value, allowing the sampling of the high
Q values. In the cases of GH:(GHR)2 and PRL:(PRLR)2, the
extended N-terminal tail of the cytokine enforces the asymmetry in
c by providing an additional interaction surface for N2
configurations with c higher than the native value. Recent
experimental results of Jomain et al. [21] have implicated a role
of the PRL N-terminal tail in receptor activation. The dictation of
the transient-complex ensemble by the interface shape is
reminiscent of observations on the binding of a ribotoxin to an
RNA loop on the ribosome [29]; there ribosomal proteins around
the binding interface were found to shift the positioning of the
transient-complex ensemble.
Receptor activation model combining scissor-like
rotation and self-rotation
Our transient-complex calculations revealed the ECD orienta-
tional rearrangements of the three receptor dimers induced by the
binding of the corresponding cytokines. These orientational
rearrangements are similar, involving both self-rotation and
scissor-like rotation, and are largely dictated by the shape of
binding interface.
The orientational rearrangement of the ECDs has to be
transmitted via the TMHs to the ICDs, to properly position and
orient the associated JAK2 molecules for transphosphorylation.
Based on our previous study [23] and the present results on the
three cytokine-receptor systems, we propose a common model for
receptor activation illustrated in Figure 4 (see also Supplementary
Video S1). First a cytokine binds to an unoccupied receptor R1 via
site 1 to forms a 1:1 complex. Then R2 in the preformed dimer
approaches site 2. Initially the ECD N-terminal subdomains of R1
and R2 are separated at ,180u and the membrane-proximal ends
of the two ECD C-terminal subdomains are apart. Subsequently
the two ECDs undergo scissor-like rotation to bring together the
membrane-proximal ends of the two C-terminal subdomains, and
simultaneously self-rotation to reduce the angle between the N-
terminal subdomains. As a result of the scissor-like rotation, the
ECD-TMH linkers and the N-terminals of the TMHs move closer,
while the C-terminals of the TMHs and the box-1 regions of the
ICDs are separated, making room for the associated JAK2
molecules. Meanwhile the self-rotation allows the JAK2 molecules
to orient properly for transphosphorylation.
Our calculations were based on the structures of the 1:2
complexes of the three cytokines with the corresponding receptor
ECDs. These structures are likely preserved in the 1:2 complexes
involving the full-length receptors bound to cell membranes, for
the following reasons. First, structures of the receptor ECDs in apo
form and in 1:1 and 1:2 complexes with their cytokines have been
determined by different groups. As noted above, the multiple
structures for each system are all very similar, attesting to their
stability. Second, the ECD of each receptor is separated from the
TMH by a linker of ,10 residues, suggesting minimal perturba-
tion of the ECD by the TMH in the full-length receptor. While
separating the ECDs from the TMHs, the linkers play the
important role of relaying the rotational motions of the ECDs to
the TMHs. (A similar role was identified for an inter-domain
linker in the activated of a ligand-gated ion channel [30].)
The ECD orientational rearrangements of the receptor dimers
determined here occur after the two receptor molecules are loosely
bound, and thus the fact that the molecules reach this state via
diffusion in the 2-dimensional membrane has no bearing. The
resulting motions of the TMHs and box-1 regions are speculated,
but seem to be supported by a host of experimental observations,
as we detail below.
Incomplete rotation leads to partial agonist or antagonist
Our transient-complex calculations identified a common
rotational pathway that receptor dimers are likely to follow upon
ligand binding. If the rotations induced are incomplete, then the
ligand will likely act as a partial agonist or antagonist. This
conclusion is supported by the EPOR partial agonist EMP1 and
antagonist EMP33. In EMP1:(EPOR)2, c=168u and Q=39u
(Figure 2C). Both values are higher than the counterparts in
EPO:(EPOR)2, just like those in the transient complex of
EPO:(EPOR)2 (Figure S2). That is, in terms of receptor
orientational arrangement, EMP1:(EPOR)2 and the transient
complex of EPO:(EPOR)2 deviate from EPO:(EPOR)2 from the
same direction. The receptor configuration induced by EMP1 can
thus be viewed as an intermediate along the way to the fully
activated configuration as found in EPO:(EPOR)2, explaining why
EMP1 is only a partial agonist. In EMP33:(EPOR)2, c=182u and
Q=38u (Figure 2C), the former angle deviating even more than
that in EMP1:(EPOR)2 from the counterpart in EPO:(EPOR)2.
The receptor configuration induced by EMP33 is thus an earlier
intermediate compared to that induced by EMP1, and hence
EMP33 is an antagonist. The fact that EMP1 is a partial agonist
but EMP33 is an antagonist despite the similar Q angles of
EMP1:(EPOR)2 and EMP33:(EPOR)2 directly supports our
contention that both scissor-like rotation and self-rotation are
required for receptor activation (see below for further discussion).
We also calculated the transient complexes formed by EMP1
and EMP33 with EPOR, and found that they too followed the
common rotational pathway of the GH-GHR, EPO-EPOR, and
PRL-PRLR systems. The distributions of c and Q for the EMP1
and EMP33 transient-complex ensembles are shown in Figure S2.
Figure S5 displays 5 representative configurations each for the
EMP1 and EMP33 transient complexes. Clockwise self-rotation
(top view) and scissor-like rotation (side view) similar to those
shown in Figure 3 are also seen in approaching the native
complexes here.
From the distributions of c and Q in Figure S2, it can seen that
the EMP33 transient complex is comprised of configurations
closely clustered around the EMP33 native complex, and they all
fall inside the configurational space of the EMP1 transient
complex. It appears that EMP33 locks the receptor dimer in the
configurations found in the EMP1 transient complex and prevents
it from further orientational rearrangement toward more active
configurations. EMP33 differs from EMP1 by two additional
bromine atoms on Tyr4 residues (located in site 1 and site 2) of the
dimeric ligand. The additional contacts seem key to the locking
action of EMP33.
Our analysis on the complexes of EMP1 and EMP33 with
EPOR suggests a strategy for designing antagonists based on
transient-complex calculations. One first uses the configurations
Figure 3. Representative configurations of the transient complexes. (A)–(C) Top views are on the left, side views are on the right, and
cytokine names are listed in the middle. R1 is shown with N1 in purple and C1 in orange. Each R2 configuration is displayed with color varying from
blue at the N-terminal to red at the C-terminal. N2 is not shown in the side views.
doi:10.1371/journal.pcbi.1002427.g003
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ligands (like EMP1) that stabilize these transient-complex
configurations may be candidates for partial agonists. In the next
iteration, configurations constituting the transient complex of a
thus designed partial agonist become targets; ligands (like EMP33)
that stabilize the new generation of transient-complex configura-
tions may be candidates for antagonists. This process may be
further iterated.
Both scissor-like rotation and self-rotation are required
for activation
Constitutively active receptors obtained by Seubert et al. [16]
and Brown et al. [10] through deletion or insertion mutations on
TMHs demonstrate the involvement of self-rotation in receptor
activation. Insertions and deletions move residues on the C-
terminal side of the point of mutation along the helical wheel. This
has the same effect as self-rotation on the associations JAK2s. Each
deleted (inserted) residue in the TMH corresponds to a 103u
counterclockwise (clockwise) rotation (top view). Starting with the
state in which R2 is loosely bound to the 1:1 complex (Figure 4C),
we find that, after either deleting three residues or inserting four
residues on the TMHs, the associated JAK2s are oriented in
proximity (Figure S6), similar to that brought about by the
receptor self-rotation in our activation model (Figure 4D). These
are precisely the numbers of deleted and inserted residues that
Seubert et al. [16] and Brown et al. [10] found to result in
constitutive activity. We emphasize, however, both self-rotation
and scissor-like rotation are required in our model of receptor
activation. We note that the dimeric coiled coil replacing the
ECDs in the constitutively active EPOR mutant engineered by
Seubert et al. [16] would likely bring the N-terminals of the TMHs
together, thus achieving the same effect as cytokine-induced
scissor-like rotation.
Other experimental observations also support the proposed role
of scissor-like rotation in receptor activation. Zhang et al. [31]
found that a disulfide linkage between Cys241 residues, located in
the middle of the ECD-TMH linkers (Figure 4), occurred only
after forming the GH:(GHR)2 complex. This observation suggests
that the ECD-TMH linkers are apart before GH binding and
come into contact in the 1:2 complex. This movement of the
linkers is just what is brought about by the scissor-like rotation of
R1 and R2 (Figure 4).
Brooks et al. [32] using FRET observed that GHR ICDs moved
part by ,9A ˚ in an active receptor dimer relative to an inactive
dimer. They concluded that reorientation (akin to our self-
rotation) is critical but insufficient for full activation. Their
observation and conclusion are in line with our model of receptor
activation.
Figure 4. Model for receptor activation. The cytokine and ECDs of
the two receptor molecules are colored in the same scheme as in
Figure 1. The ECD-TMH linkers are represented by red lines, and the
TMHs are represented by lime green coils. Residue Cys241 in GHR is at
the midpoint of the ECD-TMH linker. The ICDs are in turquoise green
and JAK2s are in yellow. (A) In the preformed dimer, the two ECDs are
apart, but the TMHs and ICDs are in contact; the associated JAK2s are
oriented away from each other. (B) The cytokine binds to R1 via site 1 to
form the 1:1 complex. (C) R2 approaches site 2 of the cytokine in the 1:1
complex, resulting in a loose complex in which the N-terminal
subdomains of the two ECDs are nearly anti-parallel and the
membrane-proximal ends of the two C-terminal subdomains are apart.
(D) Scissor-like rotation of R1 and R2 leads to separation of the ICDs,
making room for the JAK2s to approach each other. Self-rotation of R2
(and R1 to a lesser extent) further allows the JAK2s to orient properly for
transphosphorylation.
doi:10.1371/journal.pcbi.1002427.g004
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Brown et al. [10] on PRLR. In contrast to the results of Brown et
al. for GHR, Liu and Brooks did not find any constitutively active
dimer after inserting up to four alanines. Since it takes seven
residues to cover all positions on a helix wheel, insertions of five
and six alanines would be required to complete the full range of
relative orientation of the two TMHs. It is possible that the five- or
six-alanine insertion mutant would be constitutively active. It is
also possible that none of these alanine-insertion PRLR mutants
has sufficient scissor-like rotation for activation.
Other experiments can be designed to further test our model of
cytokine receptor activation. For example, inter-receptor distances
at different positions along the z axis could be obtained by double
cross-linking with bifunctional reagents, which bridge between two
receptor molecules and can be used as molecular rulers [34]. The
distances, before and after cytokine binding, between residues in
the ECD-TMH linkers and between residues in the box-1 regions
will be particularly useful for validating and refining our model. It
will then even be worthwhile to start building structural models for
receptor constructs that are truncated only after the box-1 region,
as either preformed dimer or in an activated complex.
Orientational rearrangements such as self-rotation have been
implicated in the activation of thrombopoietin receptor and many
tyrosine kinase receptors [35–37]. The detailed activation model
presented here for three cytokine receptors and our approach
based on transient-complex calculations will be useful for
elucidating the activation mechanisms of a wide range of
receptors.
In conclusion, our calculations suggest that R2 undergoes a
combined scissor-like rotation and self-rotation to reach the
activated state upon binding to the cytokine-R1 complex. The
similar observations in all the three cytokine-receptor systems
allow us to propose a common model for class I cytokine receptor
activation. Both the scissor-like and self-rotation are required for
the activation
Methods
Structure preparation for native complexes
The implementation of our transient-complex theory used the
structures of native complexes as input. Here native complex
referred to a 1:2 complex comprised of one cytokine molecule and
two receptor molecules. The structures of the 1:2 complexes of the
GH-GHR, EPO-EPOR, PRL-PRLR, EMP1-EPOR, and
EMP33-EPOR systems were from Protein Data Bank entries
3HHR [1], 1EER [6], 3NPZ [7], 1EBP [14], and 1EBA [15],
respectively. In the complex containing either EMP1 or EMP33,
the EPO mimetic peptide was present as a dimer. All hydrogen
atoms were added and energy minimized by the AMBER
program.
The N-terminal tail of GH (residues 1 to 5) changes orientation
on going from the 1:1 complex to the 1:2 complex, from extending
sideways to wrapping around R2. We used the orientation of the
N-terminal tail of GH in the 1:1 complex, but counted those N-
terminal residues in touch with R2 in the 1:2 complex when
calculating contacts for determining the transient complex (see
below).
The N-terminal tail of PRL (residues 1 to 10) is disordered in
both the 1:1 and 1:2 complexes, and shows an ensemble of
conformations in the NMR structure of the unbound state (Protein
Data Bank entry 1RW5) [38]. Jomain et al. [21] implicated a role
of the N-terminal tail in receptor activation. We thus chose to
build the N-terminal tail by Modeller (version 9v8) [39], in an
orientation wrapping R2 and similar to that in one of the NMR
models for the unbound PRL. To further mimic the situation with
the GH-GHR system, we pulled the N-terminal tail so that it
extended sideways. The subsequent treatment of this N-terminal
tail when determining the transient complex was the same as
described for the GH-GHR system.
Implementation of the transient-complex theory
The implementation of our transient-complex theory for
protein-protein association has been described previously [23–
25]. Briefly, while fixing the 1:1 complex in space, R2 was
translated and rotated around the native-complex configuration.
The three translational degrees of freedom were represented by
the displacement vector r between the centers of the binding
surfaces on the two subunits. The binding surfaces were defined by
heavy atoms making ,5A ˚ cross-interface contacts in the native
complex. Of the three rotational degrees of freedom, two were a
unit vector e attached to the mobile R2 and the remaining one
was the rotational angle x around the unit vector. The unit vector
was perpendicular to the least-squares plane of the interface heavy
atoms.
To sample the native-complex energy well and the transition
region to the unbound state, the six translational and rotational
coordinates (r, e, x) were randomly generated, with the
magnitude, r,o fr restricted: r#rcut. The value of rcut was
automatically determined to ensure that the clash-free fraction of
the randomly generated configurations was $10
24 [25]. The
resulting rcut values were 6, 6, 12, 6, and 7 A ˚ for the GH-GHR,
EPO-EPOR, PRL-PRLR, EMP1-EPOR, and EMP33-EPOR
systems, respectively. Clash between the 1:1 complex and R2
was detected exhaustively over all inter-subunit atom pairs.
For each clash-free configuration, the total number, Nc,o f
contacts, either native or nonnative, made by a list of ‘‘interaction-
locus’’ atoms across the binding interface was calculated as a
surrogate of short-range interaction energy. The interaction-locus
atoms were selected from the interface atoms as follows. Native
pairs of the interface heavy atoms were sorted in ascending order
of interatomic distances; each pair was then evaluated against
preceding pairs for possible elimination. Specifically, a pair was
eliminated if it was within 3.5 A ˚ of a preceding pair on either side
of the interface. The final remaining list constituted the
interaction-locus atoms. The purpose of the selection process
was twofold: to increase the chance that retained native pairs were
distinct from each other; and to decrease the chance of nonnative
contacts so that there was a proper balance between native and
nonnative contacts. The value of Nc in a randomly generated
configuration was calculated by counting the number of native
contacts and nonnative contact. The upper limit in distance for
forming a native contact was the native distance plus 3.5 A ˚.T o
count nonnative contacts, the native distance of each native pair
was split in half to define the contact radii of the two atoms. A
nonnative contact was considered formed when the interatomic
distance was less than the sum of their contact radii plus 2.5 A ˚.
The Nc values of the GH-GHR, EPO-EPOR, PRL-PRLR,
EMP1-EPOR, and EMP33-EPOR native complexes were 56, 32,
81, 31 and 44, respectively. As the two subunits moved apart, Nc
decreased gradually and the range of allowed rotation angles, as
indicated by the standard deviation in x of the clash-free
configurations, increased sharply. The midpoint of this sharp
transition (where Nc;Nc*) defined the transient complex (Figure
S7) [25]. From 8610
6 clash-free configurations, the values of Nc*
were determined to be 12, 15, 16, 19, and 13, respectively, for the
five systems, and the 9,114, 48,078, 2,276, 19,407, and 13,361
configurations with these respective Nc values constituted the
transient-complex ensembles.
Activation Mechanism of Cytokine Receptors
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complex and the electrostatic interaction energy within the
transient complex, the transient-complex theory further predicts
the protein association rate constant in solution. Details of these
two components and the calculated rate constants are given in
Supporting Text S1.
Supporting Information
Figure S1 Histograms of c and Q angles of the GH:(GHR)2
transient complex. 6,354 transient-complex configurations are
used for calculating the histograms. Vertical dashed lines indicate c
and Q values in the native complex.
(TIF)
Figure S2 Histogram of c and Q angles of the EPO:(EPOR)2,
EMP1:(EPOR)2, and EMP33:(EPOR)2 transient complexes.
4,442, 5,760, and 5,994 configurations, respectively, are used for
calculating the histograms of the three systems. Vertical dashed
lines indicate c and Q values in the native complexes.
(TIF)
Figure S3 Histogram of c and Q angles of the PRL:(PRLR)2
transient complex. 2,276 transient-complex configurations are
used for calculating the histograms. Vertical dashed lines indicate c
and Q values in the native complex. The two peaks in the c
histogram, to the right and left of the native value, correspond to
R2 configurations forming contact mainly with the N-terminal tail
and with the rest of the cytokine, respectively.
(TIF)
Figure S4 The role of a loop in the C1 subdomain in
determining the asymmetric distribution of the transient-complex
ensemble. This loop, illustrated here in blue on the GH-GHR
system, is between strands A and B. GH and R1 are in gray; native
R2 is in lime green; and a R2 configuration in the transient
complex is in red. An R2 configuration with a Q angle lower than
the native value would have its C2 subdomain positioned toward
the foreground of the present view and would likely clash with the
C1 loop. In contrast, the R2 configuration shown in red has a Q
angle higher than the native value, and the C2 subdomain,
positioned toward the background, is opposite to a flat surface of
C1. The extended N-terminal (in yellow) of GH ‘‘attracts’’ R2
configurations (such as the one shown in red) with c angles higher
than the native value.
(TIF)
Figure S5 Representative configurations of the transient com-
plexes of two EPO mimetic peptides. (A) EMP1:(EPOR)2. (B)
EMP33:(EPOR)2.
(TIF)
Figure S6 Reorientation of JAK2s resulting from deleting or
inserting TMH residues. Top view of the ICDs and the associated
JAK2s are shown; a shaded rectangle represents the cell
membrane. An a-helix has ,3.5 residues per turn, so each
residue spans ,360u/3.5=103u of the helical wheel. (Left)
Deleting each TMH residue would rotate the associated JAK2
counterclockwise for 103u; (Right) Inserting each TMH residue
would rotate the associated JAK2 the same amount but in the
opposite direction. Negative and positive numbers indicate the
total numbers of deleted and inserted TMH residues. Shown in
highlight are the three-residue deletion and four-residue insertion,
both of which orient the two JAK2 in proximity, ready for
transphosphorylation.
(TIF)
Figure S7 Locating the transient complex. (A) GH:(GHR)2. (B)
EPO:(EPOR)2 (C) PRL:(PRKR)2. sx represents the standard
deviation of the x angles sampled by the clash-free configurations
at a given Nc. Symbols represent raw data from the randomly
generated clash-free configurations; curve represents the fit to a
function used for modeling protein denaturation data as two-state
transition. The ‘‘baseline’’ with low sx (and high Nc) correspond to
configurations in the native-complex well. The ‘‘baseline’’ with
high sx (and low Nc) correspond to the start of the unbound state.
The midpoint of the transition, where Nc is designated Nc*,
identifies the transient complex.
(TIF)
Text S1 Methods for calculating association rate constants in
solution and results.
(DOC)
Video S1 Video illustrating our model for receptor activation.
(AVI)
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